Cancer Clinical Trials

Clinical trials are research studies for cancer treatments that are still in the development phase.

The Mon Health Cancer Center is committed to participation in clinical trials for our patients on a case-by-case basis. As an affiliate member of NRG Oncology, we have the ability to offer clinical trials associated with the leading oncology research centers and national cooperative groups.

It’s important to note that, for many reasons, not all patients will be eligible for a clinical trial. There are very strict patient eligibility requirements that are specific to each clinical trial.  We look forward to the opportunity to discuss this possible option with you.

Clinical trials are done in phases. Each phase has a different purpose, the National Institute of Health says:

• Phase I trials use a small group of people, usually 20-80, to check the safety, dosage and side effects of a treatment.
• Phase II trials expand to 100-300 people and look at the effectiveness and safety of a treatment.
• Phase III trials include 1,000-3,000 people and try to confirm the results of the earlier trials and compare the new treatment with other commonly used treatments.

Mon Health Medical Center primarily focuses on Phase II and Phase III trials. If interested, please speak to your doctor or call our Clinical Trial Coordinator at 304-598-6581.

If you would like to learn more about clinical trials, here are some useful links:

ClinicalTrials.gov—a worldwide clinical studies database from the US National Institutes of Health 
Cancer.gov—a cancer-specific resource on clinical trials from the National Cancer Institute at the National Institutes of Health
NRG Oncology – a resource for the clinical trials by the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG) and the Gynecologic Oncology Group (GOG)